Whanin Pharm (016580) — Cash Flow Reinvestment Rate
Whanin Pharm (016580) has a Cash Flow Reinvestment Rate of 0.18x as of December 2025, reinvesting ₩419.66 Million (capex ₩419.66 Million plus investments ₩-10.00) from operating cash flow of ₩2.38 Billion. Explore Whanin Pharm capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Whanin Pharm Cash Flow Reinvestment Rate (2009–2025)
Historical reinvestment intensity for Whanin Pharm across 14 annual periods. Also explore Whanin Pharm assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Whanin Pharm (2009–2025)
Year-by-year capital reinvestment analysis for Whanin Pharm. For live market cap and broader valuation context, see 016580 market cap.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.90x | ₩17.17 Billion | ₩9.04 Billion | ₩6.18 Billion | ▼ -27.4% |
| 2024 | 2.61x | ₩54.11 Billion | ₩20.69 Billion | ₩29.38 Billion | ▲ +48.2% |
| 2023 | 1.76x | ₩40.92 Billion | ₩23.20 Billion | ₩31.49 Billion | ▼ -52.9% |
| 2022 | 3.75x | ₩63.14 Billion | ₩16.85 Billion | ₩33.65 Billion | ▲ +1847.1% |
| 2021 | 0.19x | ₩6.80 Billion | ₩35.32 Billion | ₩4.39 Billion | ▼ -74.0% |
| 2020 | 0.74x | ₩16.83 Billion | ₩22.75 Billion | ₩7.99 Billion | ▼ -55.0% |
| 2019 | 1.64x | ₩40.64 Billion | ₩24.73 Billion | ₩2.76 Billion | ▲ +91.1% |
| 2018 | 0.86x | ₩15.01 Billion | ₩17.45 Billion | ₩4.10 Billion | ▼ -64.5% |
| 2017 | 2.42x | ₩56.80 Billion | ₩23.48 Billion | ₩19.31 Billion | ▲ +235.1% |
| 2016 | 0.72x | ₩14.31 Billion | ₩19.82 Billion | ₩7.46 Billion | ▼ -35.5% |
| 2012 | 1.12x | ₩23.61 Billion | ₩21.11 Billion | ₩5.06 Billion | ▼ -19.9% |
| 2011 | 1.40x | ₩21.09 Billion | ₩15.12 Billion | ₩2.68 Billion | ▲ +0.0% |
| 2010 | 1.40x | ₩21.09 Billion | ₩15.12 Billion | ₩2.68 Billion | ▲ +299.8% |
| 2009 | 0.35x | ₩6.49 Billion | ₩18.61 Billion | ₩2.18 Billion | — |